**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 138-85-2 |Mercurate(1-),(4-carboxylatophenyl)hyd| 100 | 205-340-5 |
| |roxy-, sodium salt | | |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T+
Risk Phrases: 26/27/28 33
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Very toxic by inhalation, in contact with skin and if swallowed.
Danger of cumulative effects.The toxicological properties of this
material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological
properties of this substance have not been fully investigated.
Inorganic mercury compounds may cause central and peripheral nervous
system effects.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated. Acute exposure to
high concentrations of mercury vapors may cause severe respiratory
tract irritation.
Chronic:
Chronic exposure to mercury may cause permanent central nervous
system damage, fatigue, weight loss, tremors, personality changes.
Chronic ingestion may cause accumulation of mercury in body tissues.
Chronic exposure to mercury vapors may produce weakness, fatigue,
anorexia, loss of weight and gastrointestinal disturbances which is
collectively referred to as asthenic-vegetative syndrome or
micromercurialism. Chronic exposure to mercury compounds may produce
immunologic glomerular disease.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Get medical aid. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry
chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid ingestion and
inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Poison room
locked.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 138-85-2:
United States OSHA: 0.1 mg/m3 Ceiling (listed under Mercury, ary
and inorganic compounds).
Belgium - TWA: (listed as mercury, aryl and inorganic compounds):
mg/m3 VLE (as Hg)
France - VME: (listed as mercury, aryl and inorganic compounds):
mg/m3 VME (as Hg)
Germany: (listed as mercury, aryl and inorganic compounds): 0.1 m
VME (as Hg)
Malaysia: (listed as mercury, aryl and inorganic compounds): 0.1
mg/m3 TWA (as Hg)
Spain: (listed as mercury, aryl and inorganic compounds): 0.1 mg/
VLA-ED (as Hg)
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 0 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: slightly soluble in water
Specific Gravity/Density:
Molecular Formula: C7H5HgNaO3
Molecular Weight: 360.69
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon
dioxide, mercury/mercury oxides, sodium oxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 138-85-2: OV8150000
LD50/LC50:
Not available.
Carcinogenicity:
Mercurate(1-),(4-carboxylatophenyl)hydroxy-, sodium salt -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: PHENYLMERCURIC COMPOUND, N.O.S.
Hazard Class: 6.1
UN Number: 2026
Packing Group: II
IMO
Shipping Name: PHENYLMERCURIC COMPOUND, N.O.S.
Hazard Class: 6.1
UN Number: 2026
Packing Group: II
RID/ADR
Shipping Name: PHENYLMERCURIC COMPOUND, N.O.S.
Hazard Class: 6.1
UN Number: 2026
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T+
Risk Phrases:
R 26/27/28 Very toxic by inhalation, in contact with
skin and if swallowed.
R 33 Danger of cumulative effects.
Safety Phrases:
S 13 Keep away from food, drink and animal feeding
stuffs.
S 28A After contact with skin, wash immediately with
plenty of water.
S 36 Wear suitable protective clothing.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 138-85-2: No information available.
Canada
CAS# 138-85-2 is listed on Canada's DSL List.
CAS# 138-85-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 138-85-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 7/09/1999 Revision #3 Date: 1/18/2005
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Trolox, 97%
| 53188-07-1 |
|
Poly(2,2-Dimethyl-1,3-Propylene Succinate) Approximate M.W. 16.000
| 28776-65-0 |
|
1-Benzyl-2-methylimidazole, 95%(gc)
| 13750-62-4 |
|
2-Phenyl-2-imidazoline, 98+%
| 936-49-2 |
|
Pyridazine, 98+%
| 289-80-5 |
|
Butyraldehyde, P.A. Contains Less Than 1% Butyric Acid
| 123-72-8 |
|
2,3-Dimethoxyphenol, 99%
| 5150-42-5 |
|
4-Octylbenzaldehyde, 99% (GC)
| 49763-66-8 |
|
4-Aminophenethyl alcohol, 97% (gc)
| 104-10-9 |
|
2,6-Dinitrotoluene, 99%
| 606-20-2 |
|
Methanethiol, 99.5+%
| 74-93-1 |
|
Benzanilide 98%
| 93-98-1 |
|
2-Amino-6,8-Dihydroxypurine, Tech., ca.85% (HPLC)
| 5614-64-2 |
|
2-Dimethylaminoethyl Methacrylate, 99% (GC), Stabilized
| 150-76-5 |
|
Butyric Acid, Sodium Salt, 99%
| 156-54-7 |
|
N,n',n",n"'-tetraacetylglycoluril, 98+%
| 10543-60-9 |
|
2-Ethylhexyl Acetate, 99% (GC)
| 103-09-3 |
|
Alpha, Alpha, Alpha-Trifluoro-O-Toluic Acid, 98%
| 433-97-6 |
|
Deuterium Oxide, 99.8 Atom % D
| 7789-20-0 |
|
Phenothiazine-10-carbonyl chloride 98%
| 18956-87-1 |
|
4-Chloro-2-Nitrotoluene, 99%
| 89-59-8 |
|
1,12-Dodecanedicarboxylic Acid, 98%
| 821-38-5 |
|
Lead(II) carbonate, basic, -325 mesh
| 1319-46-6 |
|
4'-Chloro-2'-Fluoroacetanilide , 99+%(TLC)
| 59280-70-5 |
|
2-Benzoylbenzoic acid, 98+%
| 85-52-9 |
|
d-(+)-Galactosamine Hydrochloride, 99%
| 1772-03-8 |
|
2-Benzylpyridine, 98%
| 101-82-6 |
|
Trypan Blue
| 72-57-1 |
|
Ethyl caprylate, 99+%
| 106-32-1 |
|
4-(Hydroxymercury)benzoic acid sodium salt
| 138-85-2 |
|
(2S,3S),(2S,3R)-2-Amino-3-Hydroxy-4-Methyl Pentanoic Acid, 99+% e.e.
| 0-01-1 |
|
Ethylenediamine-N,N'-diacetic acid, 98+%
| 5657-17-0 |
|
2-Acetoxy-3,3-dichlorotetrahydrofuran 98+%
| |
|
2-Nitroaniline, 98%
| 88-74-4 |
|
DL-Homatropine Hydrobromide, 98.5-100.5% (on Dry Subst.)
| 51-56-9 |
|
4-Methyl-3-nitroanisole, 99%
| 17484-36-5 |
|
Chromotrope 2b
| 548-80-1 |
|
3-Hydroxytyramine hydrobromide, 99%
| 51-61-6 |
|
1,4-Bis(2-Hydroxyethoxy)-2-Butyne
| 1606-85-5 |
|
Oxonic acid, potassium salt, 97.5%
| 2207-75-2 |
|
(-)-Chiracamphox
| 165038-32-4 |
|
Iminodiacetonitrile, 98%
| 628-87-5 |
|
Heptanoyl chloride, 99%(titr.)
| 2528-61-2 |
|
Azocarmine G (Cert)
| 25641-18-3 |
|
New Coccine
| 2611-82-7 |
|
(2-Fluorophenyl)(4-methoxy-3-nitrophenyl) methanone, 95%
| |
|
1-Chloropropane, 99%
| 540-54-5 |
|
2-Methylglutaric acid, 99%
| 18069-17-5 |
|
3,4,5-Trimethoxyaniline, 97%
| 24313-88-0 |
|
5-Chloro-2-(trichloromethyl)benzimidazole , 95%
| 3584-66-5 |
|
|